Silent bacterial genes yield potential leads for future cancer drugs

Natural products produced by microorganisms are a promising source of new drugs. Researchers at the Helmholtz Center for Infection Research (HZI) and its Saarbrücken-based site, the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), have now discovered a new family of such compounds, elucidated their unusual biosynthesis and developed a way to produce them synthetically.

NewsBeagle is a discovery engine. We show the headline, a short source-supplied summary and clear attribution. The complete reporting remains with the publisher.